Responses
Immunotherapy biomarkers
Original research
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma
Compose a Response to This Article
Other responses
No responses have been published for this article.